Justera Health Past Earnings Performance
Past criteria checks 0/6
Justera Health's earnings have been declining at an average annual rate of -4.1%, while the Healthcare industry saw earnings growing at 16.2% annually. Revenues have been declining at an average rate of 74% per year.
Key information
-4.1%
Earnings growth rate
18.3%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | -74.0% |
| Return on equity | n/a |
| Net Margin | -70.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Justera Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -1 | 3 | 0 |
| 31 Mar 24 | 1 | -2 | 4 | 0 |
| 31 Dec 23 | 2 | -3 | 4 | 0 |
| 30 Sep 23 | 5 | -3 | 3 | 0 |
| 30 Jun 23 | 7 | -4 | 4 | 0 |
| 31 Mar 23 | 11 | -6 | 5 | 0 |
| 31 Dec 22 | 15 | -5 | 5 | 0 |
| 30 Sep 22 | 15 | -11 | 5 | 0 |
| 30 Jun 22 | 16 | -8 | 5 | 0 |
| 31 Mar 22 | 17 | -5 | 4 | 0 |
| 31 Dec 21 | 20 | -9 | 4 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Quality Earnings: VTAL is currently unprofitable.
Growing Profit Margin: VTAL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VTAL is unprofitable, and losses have increased over the past 5 years at a rate of 4.1% per year.
Accelerating Growth: Unable to compare VTAL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VTAL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.4%).
Return on Equity
High ROE: VTAL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.